Keli Walbert joined Horizon in 2018 and has more than 25 years of pharmaceutical and health care industry experience primarily focused on building integrated marketing teams and leading medicine launches. She previously led the U.S. commercial organization, overseeing the infused medicines portfolio, including the Horizon launches of TEPEZZA and UPLIZNA, life-cycle management and consumer and digital marketing. She currently leads Horizon’s strategic and corporate marketing.

Before joining Horizon, Walbert was with AbbVie where she led the consumer, advocacy and patient services functions as well as the overall launch of a drug-device combination product, DUOPA. Before AbbVie, she built and led the consumer organization at Abbott (now AbbVie) for the launch of HUMIRA. Walbert also held senior marketing and advertising leadership roles at the American Medical Association (AMA) and Draft Worldwide (now FCB), a global advertising agency.

Walbert has a bachelor’s degree in communication from the University of Louisville and a master’s degree in marketing communications from Northwestern University.